熱門資訊> 正文
Purple Biotech首席执行官吉尔·埃夫隆(Gil Efron)辞职
2026-03-13 20:31
- Purple Biotech (PPBT) on Friday said that Gil Efron will step down from his role as CEO effective August 2026.
- Efron has served in senior leadership roles at Purple Biotech for the past eight years, including as Chief Financial Officer and, since 2022, as Chief Executive Officer.
- Source: Press Release
More on Purple Biotech
- Seeking Alpha’s Quant Rating on Purple Biotech
- Historical earnings data for Purple Biotech
- Financial information for Purple Biotech
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。